RankAlpha logo
Back to Rankings

PFE

PfizerB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
PFE vs peer average
56/100
PFE vs. peer average (B vs. B)
Grade spread
A 3 · B 3 · C 1 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Large-cap biopharma peer with a broad commercial base and pipeline; relevant for comparing post-LOE portfolio replacement and capital allocation discipline.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
PFE
Pfizer
AMGN
Amgen
Grade
B
D
Momentum
66
70
Value
65
63
Sentiment
62
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs AMGN

PFE / AMGN
Grade Position
In line
PFE vs. peer average (B vs. B)
56/100
Momentum
66
AMGN
Value
65
PFE
Sentiment
62
PFE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PFE
1
AMGN
AMGN
D
40/100
+2
2
GILD
GILD
B
80/100
Even
3
REGN
REGN
B
80/100
Even
4
DHR
Danaher Corp Common
D
40/100
+2
5
BMY
Bristol-Myers Squibb Co Common
C
60/100
+1
AMGN is the first peer returned for this comparison set.